Immunome Appoints Corleen Roche as Chief Financial Officer

EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell discovery engine platform to discover and develop first-in-class antibody therapeutics, this week announced the appointment of Corleen Roche as Chief Financial Officer. Ms. Roche is a highly accomplished CFO with an extensive background in corporate finance and strategy in the biopharmaceutical industry, and served most recently as the US CFO for Biogen.